Operating
Zimmer Biomet Holdings·Cash Flow Statement·9 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | $369.4M | $395.7M | $506.3M | $382.8M | $378.2M | $418.7M | $517.4M | $359.4M |
| Depreciation and amortization | $243.2M | $250.9M | $263.6M | $254.4M | $271.8M | $283.6M | $284M | $270M |
| Change in accounts payable | -$62.1M | -$23.2M | -$117.3M | -$36.4M | $76.8M | -$51.5M | $112.9M | -$183M |
| Stock-based compensation | $26.4M | $24.5M | $21.1M | $19.6M | $21.2M | $25.3M | $24.1M | $24.2M |
| Other working capital changes | $11.3M | $2.8M | -$85.5M | $100K | -$8.4M | -$15.8M | $35.1M | -$23.5M |
| Change in inventories | — | — | -$87.9M | $3M | $37.2M | $46M | -$184.4M | $20.9M |
| Change in receivables | — | $29.9M | $49.6M | $18.8M | — | — | $111.7M | -$14.5M |
| Change in income taxes payable/receivable | -$95.9M | -$76.7M | — | -$15.6M | -$116.4M | -$42.7M | $0 | -$7.4M |
| Deferred income taxes | -$11.9M | -$11.9M | -$11.9M | -$21.8M | -$21.8M | -$21.8M | -$21.8M | — |